KR20110033454A - Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof - Google Patents
Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof Download PDFInfo
- Publication number
- KR20110033454A KR20110033454A KR1020090090957A KR20090090957A KR20110033454A KR 20110033454 A KR20110033454 A KR 20110033454A KR 1020090090957 A KR1020090090957 A KR 1020090090957A KR 20090090957 A KR20090090957 A KR 20090090957A KR 20110033454 A KR20110033454 A KR 20110033454A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- formula
- chemical formula
- hydrogen
- mmol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
Abstract
Description
본 발명은 생체 분자 영상이나 진단, 치료에 쓰이는 친유성 나노입자에 형광 표지가 가능한 신규 시아닌 화합물 및 그 제조 방법에 관한 것이다.The present invention relates to a novel cyanine compound capable of fluorescently labeling lipophilic nanoparticles used in biomolecular imaging, diagnosis, and treatment, and a method for producing the same.
시아닌 염료는 일반적으로 광학 및 pH 안정성이 탁월하고, 좁은 흡수 (absorption) 및 발광 (emission) 파장 범위를 가지며, 500 내지 800 nm의 형광 영역을 갖기 때문에 생체 분자의 자체 형광 영역과 중첩되지 않아 분석이 용이하며, 용매 및 용해도 특성에 따라 다소 차이는 있지만, 높은 몰흡광계수를 나타내는 등 많은 장점이 있다. 하기 화학식은 문헌에 나와 있는 시아닌 염료의 일반 구조와, 유도체로 알려져 있는 헤테로 화합물의 기본 구조이다. Cyanine dyes generally have excellent optical and pH stability, have a narrow absorption and emission wavelength range, and have a fluorescence region of 500 to 800 nm, so that they do not overlap with the self fluorescence region of the biomolecule and thus the analysis is Although it is easy, and somewhat different depending on the solvent and solubility characteristics, there are many advantages such as high molar extinction coefficient. The following chemical formulas are the general structures of the cyanine dyes in the literature and the basic structures of hetero compounds known as derivatives.
시아닌 염료로서 상업적으로 가장 많이 활용되고 있는 것은 헤테로 고리로서 인돌 (indole) 구조를 포함하고, 반응기로서 숙신이미딜 에스터기를 갖는 것이다. 하기 화학식은 상품화되어 있는 대표적인 구조로서, 지이 헬스케어 (GE Healthcare)에서 Cy3, Cy5 및 Cy7이라는 상품명으로 시판되는 것들이다.The most commercially utilized cyanine dyes include indole structures as hetero rings and succinimidyl ester groups as reactors. The following chemical formulas are typical structures that are commercially available, and are those sold under the trade names Cy3, Cy5, and Cy7 by GE Healthcare.
본 발명의 목적은 분자 영상, 진단, 치료 등에 널리 사용되고 있는 친유성 나노 입자의 표지를 위해 사용될 수 있는 신규 시아닌 화합물 및 그 제조 방법을 제공하는 것이다.An object of the present invention is to provide a novel cyanine compound that can be used for labeling lipophilic nanoparticles widely used in molecular imaging, diagnosis, treatment, and the like, and a method of preparing the same.
상기와 같은 본 발명의 목적은 다음 화학식 1로 표시되는 신규 시아닌 화합물 및 그 제조 방법을 제공하는 것에 의하여 달성된다. The object of the present invention as described above is achieved by providing a novel cyanine compound represented by the following formula (1) and a method for producing the same.
식 중에서, In the formula,
R1은 수소, 설폰산기 또는 설폰산염기이고, R 1 is hydrogen, sulfonic acid group or sulfonate group,
2개의 R2 및 R3은 각각 독립적으로 수소 또는 탄소 수 1 내지 6의 알킬기이고, Two R 2 and R 3 are each independently hydrogen or an alkyl group having 1 to 6 carbon atoms,
R4는 수소, 탄소 수 1 내지 6개의 알킬기이고, R 4 is hydrogen, an alkyl group having 1 to 6 carbon atoms,
l 및 m은 각각 독립적으로 1 내지 5의 정수이다. l and m are each independently an integer of 1-5.
기존에 시판되고 있는 숙신이미드에스터기를 가진 시아닌 염료의 경우 생체 분자 내의 아민기 등과 결합하기 위한 것으로서 친유성 나노입자와 결합 시 결합 성능에 한계가 있지만 본 발명에서 제공되는 신규 시아닌 염료는 구조 자체에 소수성을 갖도록 하여 친유성 나노입자에 표지에 적합하도록 설계되어 있어 개선된 형광 특성이 기대된다.In the case of cyanine dyes having commercially available succinimide ester groups, they bind to amine groups and the like in biomolecules, and have limited binding performance when they are combined with lipophilic nanoparticles. It is designed to have a hydrophobic property so as to be suitable for labeling lipophilic nanoparticles and improved fluorescence properties are expected.
본 발명에 따른 시아닌 염료 화합물은 대부분의 친유성 나노 입자에 적용 시의 매질인 유기 용매를 대상으로 하고 열에 대해서도 안정하도록 설계되었다.The cyanine dye compounds according to the present invention are designed to target organic solvents, which are mediums for application to most lipophilic nanoparticles, and to be stable against heat.
또한, 본 발명은 상기 화학식 1로 표시되는 신규 시아닌 화합물의 제조 방법에 관한 것이다.The present invention also relates to a method for producing a novel cyanine compound represented by the formula (1).
이하에서는 본 발명에 따른 상기 화학식 1의 화합물의 제조 방법을 설명한다. Hereinafter, a method for preparing the compound of Formula 1 according to the present invention.
본 발명에 따른 상기 화학식 1의 화합물의 제조 방법에서는 다음 화학식 2의 화합물과 화학식 3의 화합물을 반응식 1a에 예시된 바와 같이 반응시켜 화학식 4a 의 화합물을 얻고, 이를 출발 물질로서 사용한다.In the method for preparing the compound of Formula 1 according to the present invention, the compound of Formula 2 is reacted with the compound of Formula 3 as illustrated in Scheme 1a to obtain a compound of Formula 4a, which is used as a starting material.
상기 화학식 2 내지 4 및 반응식 1a에 있어서, R1, R2 및 R3은 각각 상기 화학식 1에 대하여 정의한 바와 같다.In Formulas 2 to 4 and Scheme 1a, R 1 , R 2, and R 3 are the same as defined for Formula 1, respectively.
상기 화학식 4a의 R1이 설폰산기인 경우, 화학식 4a의 화합물을 반응식 1b에 예시된 바와 같이 일반식 MOH로 표시되는 무기 염기, 바람직하게는 수산화칼륨 또는 수산화나트륨, 가장 바람직하게는 수산화칼륨으로 처리하여 R1이 설폰산염기인 화학식 4b의 화합물을 얻고, 이를 출발 물질로서 사용할 수도 있다. When R 1 of Formula 4a is a sulfonic acid group, the compound of Formula 4a is treated with an inorganic base represented by the general formula MOH, preferably potassium hydroxide or sodium hydroxide, most preferably potassium hydroxide, as illustrated in Scheme 1b. To obtain a compound of formula 4b wherein R 1 is a sulfonate group, which may be used as a starting material.
반응식 1b에 있어서, M은 칼륨 또는 나트륨이고, R2 및 R3은 각각 화학식 1에 대하여 정의한 바와 같은 것이며, 화학식 4a의 R1은 설폰산기이고, 화학식 4b의 R1은 설폰산염기이다.In Scheme 1b, M is potassium or sodium, R 2 and R 3 are each as defined for Formula 1, R 1 in Formula 4a is a sulfonic acid group, and R 1 in Formula 4b is a sulfonate group.
본 발명에 따른 상기 화학식 1 화합물을 제조함에 있어서는 먼저 상기 화학식 4a 또는 4b의 화합물을 반응식 2에 예시된 바와 같이 다음 화학식 5의 화합물과 각각 반응시켜, 화학식 6의 화합물을 얻는다. In preparing the compound of Formula 1 according to the present invention, the compound of Formula 4a or 4b is first reacted with the compound of Formula 5, respectively, as illustrated in Scheme 2 to obtain a compound of Formula 6.
상기 화학식 5 및 6과, 반응식 2에 있어서, R1, R2, R3, R4 및 m은 각각 상기 화학식 1에 대하여 정의한 바와 같고, X는 불소, 염소, 브롬 및 요오드로 구성된 군에서 선택되는 할로겐 원자이다.In Formulas 5 and 6 and Scheme 2, R 1 , R 2 , R 3 , R 4 and m are as defined for Formula 1, respectively, X is selected from the group consisting of fluorine, chlorine, bromine and iodine Is a halogen atom.
상기 반응식 2는 R4가 수소 또는 탄소 수 1 내지 6개의 알킬기인 화학식 6의 화합물을 제조하는 방법을 예시한 것이다. Scheme 2 illustrates a method of preparing a compound of Formula 6 wherein R 4 is hydrogen or an alkyl group having 1 to 6 carbon atoms.
다음으로, 상기 화학식 6의 화합물을 반응식 3에 예시된 바와 같이 다음 화학식 7의 화합물과 반응시켜 화학식 8의 화합물을 얻는다. Next, as illustrated in Scheme 3, the compound of Formula 6 is reacted with the compound of Formula 7 to obtain a compound of Formula 8.
상기 화학식 7 및 8과 반응식 3에 있어서, R1, R2, R3, R4, l 및 m은 각각 상기 화학식 1에 대하여 정의한 바와 같고, A는 수소 또는 아세틸기이다.In Formulas 7 and 8 and Scheme 3, R 1 , R 2 , R 3 , R 4 , l and m are as defined for Formula 1, respectively, and A is hydrogen or an acetyl group.
상기 화학식 7의 화합물은 l이 1인 경우 N,N-디페닐 포름아미딘 (DPF)이고, l이 2인 경우 말론알데히드 디아닐 히드로클로라이드 (MDH)이고, l이 3인 경우 글루타콘알데히드 디아닐 히드로클로라이드 (GDH)이다. The compound of Formula 7 is N, N-diphenylformamidine (DPF) when l is 1, malonaldehyde dianile hydrochloride (MDH) when l is 2, and glutaconaldehyde when l is 3. Dianyl hydrochloride (GDH).
다음으로, 상기 화학식 8의 화합물을 반응식 4에 예시된 바와 같이 상기 화학식 6의 화합물과 반응시켜 화학식 1로 표시되는 화합물을 얻는다.Next, as illustrated in Scheme 4, the compound of Formula 8 is reacted with the compound of Formula 6 to obtain a compound represented by Formula 1.
[화학식 1][Formula 1]
상기 화학식 10 및 반응식 5에 있어서, R1, R2, R3, R4 및 m은 각각 상기 화학식 1에 대하여 정의한 바와 같다.In Formula 10 and Scheme 5, R 1 , R 2 , R 3 , R 4 and m are as defined for Formula 1, respectively.
실시예Example
이하에서는 실시예 및 비교 실험을 통하여 본 발명을 더욱 상세히 설명한다. 그러나, 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위를 한정하고자 하는 것이 아니다.Hereinafter, the present invention will be described in more detail through examples and comparative experiments. However, the examples are only for illustrating the present invention and are not intended to limit the scope of the present invention.
먼저, 실시예 및 비교 실험에서 사용된 실험 장치, 분석 장비 및 시약에 대하여 설명한다. First, experimental apparatus, analytical equipment, and reagents used in Examples and Comparative Experiments will be described.
FT-NMR 분광 분석을 위한 기기로는 Bruker사의 Avance 300 및 400을 사용하였고, LC/MS에는 Varian사의 1200L Quadrupole을 사용하여, ESI (electrospray ionization) 방식으로 측정되었다. For the FT-NMR spectroscopic analysis, Bruker's Avance 300 and 400 were used, and for LC / MS, Varian's 1200L Quadrupole was used and measured by electrospray ionization (ESI).
합성된 염료의 흡수 파장 및 최대 파장에서의 흡수값은 Hewlett-Packard사의 HP 8452 배열 분광 광도계 (diode array spectrophotometer)로 측정되었고, 발광 파장 및 최대 발광 파장에서의 발광값은 Perkin Elmer사의 LS-55를 사용하여 얻었다. Absorption values at the maximum and maximum wavelengths of the synthesized dyes were measured with a Hewlett-Packard company's HP 8452 diode array spectrophotometer, and the emission values at the maximum and maximum emission wavelengths were determined using LS-55 from Perkin Elmer. Obtained using.
유기 화합물의 분리 및 정제를 위한 칼럼 크로마토그래피는 정상 (normal phase)의 경우, 실리카겔 (silica gel)로서 Merck사의 kieselgel 60 (230-400 mesh)을 사용하였고, 박층 크로마토그래피 (TLC)에는 실리카겔 60 GF254 (0.25 mm, Merck)가 도포되어 있는 유리판을 사용하고, TLC 상의 화합물 확인은 254 nm 및 365 nm의 자외선을 이용하거나, 발색제로서 인몰리브덴산 (phosphomolybdic acid) (PMA) 20 내지 30% 에탄올 용액 또는 KMnO4를 사용하였다. 역상 (reverse phase)의 경우, TLC는 실리카겔 60 RP-18 F254S (0.25 mm, Merck)가 도포되어 있는 유리판을 사용하였고, 칼럼 크로마토그래피의 경우는 Buchi사의 MPLC (medium pressure liquid chromatography) 장비인 Fraction Collector R-660에 역상 칼럼 Lichroprep RP-18 (40 내지 63 μm, Merck사 제품)를 연결하여 사용하였다. HPLC는 Agilent사의 1100 시리즈에 Waters사의 Bondapak C18 10 μm 125A를 장착하여 사용하였다.Column chromatography for the separation and purification of organic compounds used Merck's kieselgel 60 (230-400 mesh) as a silica gel in the normal phase, silica gel 60 GF254 for thin layer chromatography (TLC) (0.25 mm, Merck) was used, and the compound identification on TLC was performed using ultraviolet rays of 254 nm and 365 nm, or 20-30% ethanol solution of phosphomolybdic acid (PMA) as a colorant or KMnO 4 was used. In the reverse phase, TLC used a glass plate coated with silica gel 60 RP-18 F 254S (0.25 mm, Merck), and for column chromatography, Fraction, a medium pressure liquid chromatography (MPLC) instrument from Buchi A reverse phase column Lichroprep RP-18 (40-63 μm, available from Merck) was connected to Collector R-660. HPLC was used with Agilent's 1100 series equipped with Waterap's Bondapak C18 10 μm 125A.
시약은 주로 Aldrich사와 TCI사의 것을 사용하였다. 정제가 필요한 용매는 알려져 있는 방법에 따라 정제하여 사용하였고, 특별한 언급이 없는 한 모든 반응은 질소 기류 하에서 실시하였다. NMR 용매는 Aldrich사와 Cambridge Isotope Laboratories Inc사의 DMSO-d 6 또는 D2O를 사용하였다. 시그날의 상대적인 위치는 용매 내에 들어있는 테트라메틸실란 (tetramethylsilane, TMS)을 기준으로 하거나 NMR 용매를 기준으로 하였다. 화학전이 (chemical shift)는 표준 물질로부터 ppm 단위로 표시하였고, 데이터는 화학전이 다중도 (chemical shift multiplicity) (s=singlet, d=doublet, t=triplet, m=multiplet), intergration, coupling constant (Hz)의 순으로 기록하였다.Reagents were mainly used by Aldrich and TCI. Solvents requiring purification were used in accordance with known methods and all reactions were carried out under a nitrogen stream unless otherwise indicated. NMR solvents were DMSO- d 6 or D 2 O from Aldrich and Cambridge Isotope Laboratories Inc. The relative positions of the signals were based on tetramethylsilane (TMS) in the solvent or on NMR solvents. Chemical shifts are expressed in ppm from the standard material, and data indicate chemical shift multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), intergration, coupling constant ( Hz).
실시예 1: 화합물 1-1의 제조Example 1: Preparation of Compound 1-1
(1) 화합물 8-1의 합성(1) Synthesis of Compound 8-1
1,2,3,3-tetramethyl-3H-indoliumiodide (6.626 g, 22 mmol, 1 eq)과 glutaconaldehyde dianil hydrochloride (6.265 g, 22 mmol, 1 eq, TCI)을 16 ml acetic anhydride 혼합용액에 넣고 1 시간동안 100 도에서 반응시킨다. 상온으로 자연 냉각하고 증류수를 넣어서 입자를 얻어낸 후 여과하고 수차례 증류수로 수세한 후 감압 건조한다. (5.88 g, 54 %)1,2,3,3-tetramethyl-3H-indoliumiodide (6.626 g, 22 mmol, 1 eq) and glutaconaldehyde dianil hydrochloride (6.265 g, 22 mmol, 1 eq, TCI) were added to a 16 ml solution of acetic anhydride for 1 hour. Reaction at 100 degrees. After naturally cooling to room temperature, distilled water was added to obtain particles, followed by filtration, washed with distilled water several times, and dried under reduced pressure. (5.88 g, 54%)
Rf = 0.7 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.7 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, CDCl3) : δ 8.19-8.15 (d, J = 13.7 Hz, 1H), 7.84-6.89 (m, 13H), 5.45-5.39 (dt, J = 13.4 Hz, 11.7 Hz, 1H), 4.2 (s, 3H), 1.92 (s, 3H), 1.72 (s, 6H), 1.64 (s, 3H) 1 H NMR (400 MHz, CDCl 3 ): δ 8.19-8.15 (d, J = 13.7 Hz, 1H), 7.84-6.89 (m, 13H), 5.45-5.39 (dt, J = 13.4 Hz, 11.7 Hz, 1H ), 4.2 (s, 3H), 1.92 (s, 3H), 1.72 (s, 6H), 1.64 (s, 3H)
(2) 화합물 1-1의 합성(2) Synthesis of Compound 1-1
화합물 8-1 (3.97 g, 7.97 mmol, 1 eq)과 1,2,3,3,-Tetramethyl-3H-indolium iodide (2.39 g, 7.97 mmol, 1 eq, Aldrich)을 30 ml Pyridine 용액에 투입하여 질소상에서 교반한다. 60 도에서 1시간동안 반응시킨다. 반응완료 확인 후 상온으로 자연냉각하고 rotary evaporator를 사용하여 용매를 회수하고 감압건조 한다. methylene chloride, methanol 의 5:1 혼합 전개액으로 정상 크로마토그래피를 사용하여 순수 염료 물질을 분리한다. (1.86 g, 43.6 %)Compound 8-1 (3.97 g, 7.97 mmol, 1 eq) and 1,2,3,3, -Tetramethyl-3H-indolium iodide (2.39 g, 7.97 mmol, 1 eq, Aldrich) were added to a 30 ml Pyridine solution. Stir on nitrogen. The reaction is carried out at 60 degrees for 1 hour. After confirming the completion of the reaction, it is naturally cooled to room temperature and the solvent is recovered using a rotary evaporator and dried under reduced pressure. Pure dye material is separated by normal chromatography with a 5: 1 mixture of methylene chloride and methanol. (1.86 g, 43.6%)
Rf = 0.85 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.85 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, DMSO) : δ 7.89-7.80 (m, 2H), 7.76-7.70 (m, 1H), 7.65-7.54 (m, 3H), 7.39-7.36 (m, 5H), 6.54-6.51 (t, J = 12.6 Hz, 2H), 6.32-6.29 (d, J = 13.8 Hz, 2H), 3.57 (s, 6H), 1.70-1.62 (m, 12H) 1 H NMR (400 MHz, DMSO): δ 7.89-7.80 (m, 2H), 7.76-7.70 (m, 1H), 7.65-7.54 (m, 3H), 7.39-7.36 (m, 5H), 6.54-6.51 (t, J = 12.6 Hz, 2H), 6.32-6.29 (d, J = 13.8 Hz, 2H), 3.57 (s, 6H), 1.70-1.62 (m, 12H)
LC/MS, calculated for C29H33N2 + 409.59, found 409.21LC / MS, calculated for C 29 H 33 N 2 + 409.59, found 409.21
λabs (methanol) : 737 nm, λfl (methanol) : 774 nmλ abs (methanol): 737 nm, λ fl (methanol): 774 nm
실시예 2: 화합물 1-2의 제조Example 2: Preparation of Compound 1-2
(1) 화합물 6-1의 합성(1) Synthesis of Compound 6-1
2,3,3-trimethylindolenine (3.18 g, 20 mmol, 1 eq, Aldrich)와 Ethyl iodide (20 ml, 250 mmol, 12.5 eq, TCI)을 투입하여 질소상에서 교반한다. 24시간 동안 가열 환류 한다. 냉각하여 입자 상태를 확인 한 후 여과한다. 얻어진 고체입자를 Hexane을 사용하여 2-3회 수세한 후 감압건조 한다. (5.08 g, 80.6 %)2,3,3-trimethylindolenine (3.18 g, 20 mmol, 1 eq, Aldrich) and Ethyl iodide (20 ml, 250 mmol, 12.5 eq, TCI) were added and stirred under nitrogen. Heat to reflux for 24 hours. After cooling, check the particle state and filter. The obtained solid particles were washed 2-3 times with Hexane and dried under reduced pressure. (5.08 g, 80.6%)
Rf = 0.5 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.5 (normal phase, methylene chloride / methanol 5: 1 v / v)
(2) 화합물 8-2 합성 (2) Synthesis of Compound 8-2
화학식 6-1 (3.15 g, 10 mmol, 1 eq)과 Glutavonaldehyde dianil hydrochloride (2.85 g, 10 mmol, 1 eq, TCI)을 60 ml Acetic anhydride에 넣고 교반한다. 1시간동안 100도에서 반응 진행한 후 상온으로 자연 냉각한다. 입자를 제외한 용액을 제거한 후 Diethyl ether를 투입하여 고체입자를 생성한다. 생성된 입자를 여과한 후 감압건조 한다. (2.17 g, 42.4 %)Add Chemical Formula 6-1 (3.15 g, 10 mmol, 1 eq) and Glutavonaldehyde dianil hydrochloride (2.85 g, 10 mmol, 1 eq, TCI) to 60 ml Acetic anhydride and stir. The reaction proceeds at 100 ° C. for 1 hour and then naturally cooled to room temperature. After removing the solution except particles, Diethyl ether is added to form solid particles. The resulting particles are filtered and dried under reduced pressure. (2.17 g, 42.4%)
Rf = 0.75 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.75 (normal phase, methylene chloride / methanol 5: 1 v / v)
LC/MS, calculated for C26H29N2O+ 385.52, found 385.16LC / MS, calculated for C 26 H 29 N 2 O + 385.52, found 385.16
(3) 화합물 1-2의 합성(3) Synthesis of Compound 1-2
화학식 8-2 (5.11 g, 10 mmol, 1 eq)와 화학식 6-1 (3.15 g, 10 mmol, 1 eq)을 20 ml pyridine 용액에 넣은 후 질소상에서 교반한다. 40도 온도에서 1시간동안 반응시킨 후 상온으로 냉각한다. 얻어진 반응액을 rotary evaporator를 사용하여 용매를 회수한 후 감압 건조한다.Add Formula 8-2 (5.11 g, 10 mmol, 1 eq) and Formula 6-1 (3.15 g, 10 mmol, 1 eq) to 20 ml pyridine solution and stir on nitrogen. After reacting at 40 ° C. for 1 hour, the mixture is cooled to room temperature. The reaction solution was recovered using a rotary evaporator and then dried under reduced pressure.
methylene chloride, methanol, hexane 의 5:1:1 혼합 전개액으로 정상 크로마토그래피를 사용하여 순수 염료 물질을 분리한다. (2.13 g, 37.8 %)Pure dye material is separated by normal chromatography with a 5: 1: 1 mixture of methylene chloride, methanol, and hexane. (2.13 g, 37.8%)
Rf = 0.8 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.8 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, DMSO) : δ 7.91-7.84 (m, 2H), 7.79-7.72 (m, 1H), 7.58-7.54 (m, 3H), 7.41-7.35 (m, 5H), 6.56-6.50 (t, J = 12.6 Hz, 2H), 6.38-6.35 (d, J = 13.7 Hz, 2H), 4.12-4.09 (m, 4H), 1.68-1.62 (m, 12H), 1.32-1.24 (m, 6H) 1 H NMR (400 MHz, DMSO): δ 7.91-7.84 (m, 2H), 7.79-7.72 (m, 1H), 7.58-7.54 (m, 3H), 7.41-7.35 (m, 5H), 6.56-6.50 (t, J = 12.6 Hz, 2H), 6.38-6.35 (d, J = 13.7 Hz, 2H), 4.12-4.09 (m, 4H), 1.68-1.62 (m, 12H), 1.32-1.24 (m, 6H )
LC/MS, calculated for C31H37N2 + 437.64, found 437.20LC / MS, calculated for C 31 H 37 N 2 + 437.64, found 437.20
λabs (methanol) : 739 nm, λfl (methanol) : 774 nmλ abs (methanol): 739 nm, λ fl (methanol): 774 nm
실시예 3: 화합물 1-3의 제조Example 3: Preparation of Compound 1-3
(1) 화합물 6-2의 합성(1) Synthesis of Compound 6-2
2,3,3-trimethylindolenine (11 g, 70 mmol, 1 eq, Aldrich)와 1-iodoprapnae (70 ml, 840 mmol, 12 eq, TCI)을 투입하여 질소상에서 교반한다. 24시간 동안 가열 환류 한다. 냉각하여 입자상태를 확인 한 후 여과한다. 얻어진 고체입자를 Hexane을 사용하여 2-3회 수세한 후 감압건조 한다. (22.86 g, 99.2 %)2,3,3-trimethylindolenine (11 g, 70 mmol, 1 eq, Aldrich) and 1-iodoprapnae (70 ml, 840 mmol, 12 eq, TCI) were added and stirred over nitrogen. Heat to reflux for 24 hours. After cooling, check the particle state and filter. The obtained solid particles were washed 2-3 times with Hexane and dried under reduced pressure. (22.86 g, 99.2%)
Rf = 0.7 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.7 (normal phase, methylene chloride / methanol 5: 1 v / v)
(2) 화합물 8-3의 합성 (2) Synthesis of Compound 8-3
화학식 6-2 (10.5 g, 32 mmol, 1 eq)와 Glutavonaldehyde dianil hydrochloride (9.1 g, 32 mmol, 1 eq, TCI)을 30 ml Acetic anhydride에 넣고 교반한다. 1시간동안 100도에서 반응 진행한 후 상온으로 자연 냉각한다. 입자를 제외한 용액을 제거한 후 Diethyl ether를 투입하여 고체입자를 생성한다. 생성된 입자를 여과한 후 감압건조 한다. (11.5 g, 68.3 %)Add Chemical Formula 6-2 (10.5 g, 32 mmol, 1 eq) and Glutavonaldehyde dianil hydrochloride (9.1 g, 32 mmol, 1 eq, TCI) to 30 ml Acetic anhydride and stir. The reaction proceeds at 100 ° C. for 1 hour and then naturally cooled to room temperature. After removing the solution except particles, Diethyl ether is added to form solid particles. The resulting particles are filtered and dried under reduced pressure. (11.5 g, 68.3%)
Rf = 0.9 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.9 (normal phase, methylene chloride / methanol 5: 1 v / v)
LC/MS, calculated for C27H31N2O+ 399.55, found 399.20LC / MS, calculated for C 27 H 31 N 2 O + 399.55, found 399.20
(3) 화합물 1-3의 합성 (3) Synthesis of Compound 1-3
화학식 4c (5.26 g, 10 mmol, 1 eq)와 화학식 2b (3.29 g, 10 mmol, 1 eq)을 72 ml pyridine 용액에 넣은 후 질소상에서 교반한다. 40도 온도에서 1시간동안 반응시킨 후 상온으로 냉각한다. 얻어진 반응액을 rotary evaporator를 사용하여 용매를 회수한 후 감압 건조한다.Formula 4c (5.26 g, 10 mmol, 1 eq) and formula 2b (3.29 g, 10 mmol, 1 eq) are added to a 72 ml pyridine solution and stirred on nitrogen. After reacting at 40 ° C. for 1 hour, the mixture is cooled to room temperature. The reaction solution was recovered using a rotary evaporator and then dried under reduced pressure.
methylene chloride, methanol, hexane 의 5:1:1 혼합 전개액으로 정상 크로마토그래피를 사용하여 순수 염료 물질을 분리한다. (1.96 g, 33.1 %)Pure dye material is separated by normal chromatography with a 5: 1: 1 mixture of methylene chloride, methanol, and hexane. (1.96 g, 33.1%)
Rf = 0.75 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.75 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, DMSO) : δ 7.90-7.84 (m, 2H), 7.79-7.72 (m, 1H), 7.58-7.55 (m, 3H), 7.38-7.36 (m, 5H), 6.57-6.51 (t, J = 12.5 Hz, 2H), 6.40-6.37 (d, J = 13.6 Hz, 2H), 4.06-4.02 (m, 4H), 1.79-1.63 (m, 16H), 0.97-0.90 (m, 6H) 1 H NMR (400 MHz, DMSO): δ 7.90-7.84 (m, 2H), 7.79-7.72 (m, 1H), 7.58-7.55 (m, 3H), 7.38-7.36 (m, 5H), 6.57-6.51 (t, J = 12.5 Hz, 2H), 6.40-6.37 (d, J = 13.6 Hz, 2H), 4.06-4.02 (m, 4H), 1.79-1.63 (m, 16H), 0.97-0.90 (m, 6H )
실시예 4: 화합물 1-4의 제조Example 4: Preparation of Compound 1-4
(1) 화합물 8-4(1) Compound 8-4
1,2,3,3-tetramethyl-3H-indoliumiodide (1 g, 3.865 mmol, 1 eq)과 malonaldehyde dianil hydrochloride (1.106 g, 3.672 mmol, 0.95 eq, TCI)을 5 ml acetic acid와 5 ml acetic anhydride 혼합용액에 넣고 4시간동안 가열 환류 시킨 다. 상온으로 자연 냉각하고 반응액을 따라버린 후 ethyl acetate를 사용하여 고체입자를 생성시켜 여과하고 n-butanol로 수차례 수세한 후 감압 건조한다. (1.56 g, 90 %)Mix 1,2,3,3-tetramethyl-3H-indoliumiodide (1 g, 3.865 mmol, 1 eq) and malonaldehyde dianil hydrochloride (1.106 g, 3.672 mmol, 0.95 eq, TCI) with 5 ml acetic acid and 5 ml acetic anhydride Place in solution and heat to reflux for 4 hours. After naturally cooling to room temperature, the reaction solution was poured out, solid particles were produced using ethyl acetate, filtered, washed several times with n-butanol, and dried under reduced pressure. (1.56 g, 90%)
Rf = 0.60 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.60 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, DMSO-d 6 ) : δ 8.87-8.83 (d, J = 13.2 Hz, 1H), 8.47-8.44 (t, J = 14.9, 1H), 7.75-7.49 (m, 9H), 6.83-6.79 (d, J = 14.9, 1H), 5.62-5.59 (dt, J = 12.9 Hz, 11.5 Hz, 1H), 3.76 (s, 3H), 2.15 (s, 3H), 1.97 (s, 6H), 1.66 (s, 3H) 1 H NMR (400 MHz, DMSO- d 6 ): δ 8.87-8.83 (d, J = 13.2 Hz, 1H), 8.47-8.44 (t, J = 14.9, 1H), 7.75-7.49 (m, 9H), 6.83-6.79 (d, J = 14.9, 1H), 5.62-5.59 (dt, J = 12.9 Hz, 11.5 Hz, 1H), 3.76 (s, 3H), 2.15 (s, 3H), 1.97 (s, 6H) , 1.66 (s, 3H)
LC/MS, calculated for C23H25N2O+ 345.46, found 345.14LC / MS, calculated for C 23 H 25 N 2 O + 345.46, found 345.14
(2) 화합물 1-4(2) Compound 1-4
화합물 8-4 (5.5 g, 11.64 mmol, 1 eq)와 1,2,3,3,-Tetramethyl-3H-indolium iodide (3.51 g, 11.64 mmol, 1 eq, Aldrich)을 30 ml Acetic anhydride와 30 ml Pyridine 혼합용액에 투입하여 질소상에서 교반한다. 100도에서 4시간동안 반응시킨다. 반응완료 확인 후 상온으로 자연냉각하고 rotary evaporator를 사용하여 용매를 회수하고 감압건조 한다. methylene chloride, methanol 의 5:1 혼합 전개액으로 정상 크로마토그래피를 사용하여 순수 염료 물질을 분리한다. (2.76 g, 46.5 %)30 ml Acetic anhydride with 30 ml of compound 8-4 (5.5 g, 11.64 mmol, 1 eq) and 1,2,3,3, -Tetramethyl-3H-indolium iodide (3.51 g, 11.64 mmol, 1 eq, Aldrich) Pyridine mixed solution is added and stirred over nitrogen. The reaction is carried out at 100 degrees for 4 hours. After confirming the completion of the reaction, it is naturally cooled to room temperature and the solvent is recovered using a rotary evaporator and dried under reduced pressure. Pure dye material is separated by normal chromatography with a 5: 1 mixture of methylene chloride and methanol. (2.76 g, 46.5%)
Rf = 0.53 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.53 (normal phase, methylene chloride / methanol 5: 1 v / v)
LC/MS, calculated for C27H31N2 + 383.55, found 383.22LC / MS, calculated for C 27 H 31 N 2 + 383.55, found 383.22
실시예 5: 화합물 1-5의 제조Example 5: Preparation of Compound 1-5
(1) 화합물 8-5(1) Compound 8-5
화학식 6-1 (3.15 g, 10 mmol, 1 eq)과 malonaldehyde dianil hydrochloride (2.59 g, 10 mmol, 1 eq, TCI)을 20 ml acetic acid와 20 ml acetic anhydride 혼합용액에 넣고 4시간동안 가열 환류 시킨다. 상온으로 자연 냉각하고 반응액을 제거한 후 Diethyl ether를 사용하여 고체입자를 생성시켜 여과하고 여과한 입자는 감압건조 한다. (2.12 g, 43.5 %)Formula 6-1 (3.15 g, 10 mmol, 1 eq) and malonaldehyde dianil hydrochloride (2.59 g, 10 mmol, 1 eq, TCI) were added to a 20 ml acetic acid and 20 ml acetic anhydride solution and heated to reflux for 4 hours. . After naturally cooling to room temperature and removing the reaction solution, solid particles were produced using diethyl ether and filtered. The filtered particles were dried under reduced pressure. (2.12 g, 43.5%)
Rf = 0.65 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.65 (normal phase, methylene chloride / methanol 5: 1 v / v)
LC/MS, calculated for C22H25N2 + 317.45, found 317.14LC / MS, calculated for C 22 H 25 N 2 + 317.45, found 317.14
(2) 화합물 1-5(2) Compound 1-5
화합물 8-5 (2.32 g, 4.76 mmol, 1 eq)와 화합물 6-1 (1.5 g, 4.76 mmol, 1 eq, Aldrich)을 10 ml Acetic anhydride와 10 ml Pyridine 혼합용액에 투입하여 질소상에서 교반한다. 100도에서 4시간동안 반응시킨다. 반응완료 확인 후 상온으로 자연냉각하고 rotary evaporator를 사용하여 용매를 회수하고 감압건조 한다. methylene chloride, methanol, hexane 의 5:1:1 혼합 전개액으로 정상 크로마토그래피를 사용하여 순수 염료 물질을 분리한다. (1.05 g, 40.8 %)Compound 8-5 (2.32 g, 4.76 mmol, 1 eq) and compound 6-1 (1.5 g, 4.76 mmol, 1 eq, Aldrich) were added to a mixed solution of 10 ml Acetic anhydride and 10 ml Pyridine and stirred over nitrogen. The reaction is carried out at 100 degrees for 4 hours. After confirming the completion of the reaction, it is naturally cooled to room temperature and the solvent is recovered using a rotary evaporator and dried under reduced pressure. Pure dye material is separated by normal chromatography with a 5: 1: 1 mixture of methylene chloride, methanol, and hexane. (1.05 g, 40.8%)
Rf = 0.5 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.5 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, DMSO) : δ 8.37-8.30 (t, J = 12.9 Hz, 2H), 7.63-7.61 (m, 2H), 7.48-7.39 (m, 4H), 7.28-7.22 (m, 2H), 6.59-6.53 (t, J = 12.4 Hz, 1H), 6.31-6.28 (d, J = 13.8 Hz, 2H), 4.14-4.04 (m, 4H), 1.75-1.60 (m, 12H), 1.27-1.24 (m, 6H) 1 H NMR (400 MHz, DMSO): δ 8.37-8.30 (t, J = 12.9 Hz, 2H), 7.63-7.61 (m, 2H), 7.48-7.39 (m, 4H), 7.28-7.22 (m, 2H ), 6.59-6.53 (t, J = 12.4 Hz, 1H), 6.31-6.28 (d, J = 13.8 Hz, 2H), 4.14-4.04 (m, 4H), 1.75-1.60 (m, 12H), 1.27- 1.24 (m, 6H)
LC/MS, calculated for C29H35N2 + 411.6, found 411.23LC / MS, calculated for C 29 H 35 N 2 + 411.6, found 411.23
λabs (methanol) : 639 nm, λfl (methanol) : 664 nmλ abs (methanol): 639 nm, λ fl (methanol): 664 nm
실시예 6: 화합물 1-6의 제조Example 6: Preparation of Compound 1-6
(1) 화합물 8-6(1) Compound 8-6
화학식 2b (10.54 g, 32 mmol, 1 eq)과 malonaldehyde dianil hydrochloride (8.26 g, 32 mmol, 1 eq, TCI)을 40 ml acetic acid와 40 ml acetic anhydride 혼합용액에 넣고 4시간동안 가열 환류 시킨다. 상온으로 자연 냉각하고 반응액을 제거한 후 Diethyl ether를 사용하여 고체입자를 생성시켜 여과하고 여과한 입자는 감압건조 한다. (9.29 g, 58.1 %)Formula 2b (10.54 g, 32 mmol, 1 eq) and malonaldehyde dianil hydrochloride (8.26 g, 32 mmol, 1 eq, TCI) were added to a 40 ml acetic acid and 40 ml acetic anhydride solution and heated to reflux for 4 hours. After naturally cooling to room temperature and removing the reaction solution, solid particles were produced using diethyl ether and filtered. The filtered particles were dried under reduced pressure. (9.29 g, 58.1%)
Rf = 0.75 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.75 (normal phase, methylene chloride / methanol 5: 1 v / v)
LC/MS, calculated for C25H29N2 + 373.51, found 373.17LC / MS, calculated for C 25 H 29 N 2 + 373.51, found 373.17
(2) 화합물 1-6(2) Compound 1-6
화합물 8-6 (6.01 g, 12 mmol, 1 eq)과 화합물 6-2 (3.95 g, 12 mmol, 1 eq, Aldrich)를 60 ml Pyridine 용액에 투입하여 질소상에서 교반한다. 60도에서 4시간동안 반응시킨다. 반응완료 확인 후 상온으로 자연냉각하고 rotary evaporator를 사용하여 용매를 회수하고 감압건조 한다. methylene chloride, methanol, hexane 의 5:1:1 혼합 전개액으로 정상 크로마토그래피를 사용하여 순수 염료 물질을 분리 한다. (2.39 g, 35.2 %)Compound 8-6 (6.01 g, 12 mmol, 1 eq) and compound 6-2 (3.95 g, 12 mmol, 1 eq, Aldrich) were added to a 60 ml Pyridine solution and stirred over nitrogen. The reaction is carried out at 60 degrees for 4 hours. After confirming the completion of the reaction, it is naturally cooled to room temperature and the solvent is recovered using a rotary evaporator and dried under reduced pressure. The pure dye material is separated by normal chromatography with a 5: 1: 1 mixture of methylene chloride, methanol, and hexane. (2.39 g, 35.2%)
Rf = 0.75 (normal phase, methylene chloride/methanol 5:1 v/v)R f = 0.75 (normal phase, methylene chloride / methanol 5: 1 v / v)
1H NMR (400 MHz, DMSO) : δ 8.36-8.30 (t, J = 12.9 Hz, 2H), 7.62-7.54 (m, 2H), 7.41-7.36 (m, 4H), 7.29-7.22 (m, 2H), 6.60-6.55 (m, 1H), 6.33-6.29 (d, J = 13.8 Hz, 2H), 4.08-4.47 (m, 4H), 1.75-1.61 (m, 16H), 0.96-0.92 (m, 6H) 1 H NMR (400 MHz, DMSO): δ 8.36-8.30 (t, J = 12.9 Hz, 2H), 7.62-7.54 (m, 2H), 7.41-7.36 (m, 4H), 7.29-7.22 (m, 2H ), 6.60-6.55 (m, 1H), 6.33-6.29 (d, J = 13.8 Hz, 2H), 4.08-4.47 (m, 4H), 1.75-1.61 (m, 16H), 0.96-0.92 (m, 6H) )
LC/MS, calculated for C31H39N2 + 439.65, found 439.24LC / MS, calculated for C 31 H 39 N 2 + 439.65, found 439.24
λabs (methanol) : 641 nm, λfl (methanol) : 667 nmλ abs (methanol): 641 nm, λ fl (methanol): 667 nm
실시예 7 내지 10Examples 7-10
상기 실시예 1 내지 6에 설명된 것과 유사한 방법으로 이하의 실시예 7 내지 10의 화합물 (화합물 1-7 내지 1-10)을 제조하였다. 이들 화합물의 구조 확인 데이터는 다음과 같다.In the same manner as described in Examples 1 to 6 above, the compounds of Examples 7 to 10 (compounds 1-7 to 1-10) below were prepared. The structural confirmation data of these compounds is as follows.
실시예 7: 화합물 1-7의 제조Example 7: Preparation of Compound 1-7
Rf = 0.3 (RP-C18, acetonitrile/water 3:7 v/v)R f = 0.3 (RP-C18, acetonitrile / water 3: 7 v / v)
1H NMR (400 MHz, DMSO-d 6 ) : δ 7.90-7.84 (m, 2H), 7.79-7.73 (m, 3H), 7.63-7.61 (m, 2H), 7.31-7.28 (m, 2H), 6.57-6.50 (t, J = 12.6 Hz, 2H), 6.38-6.30 (m, 2H), 4.11-4.09 (d, J = 7.4 Hz, 4H), 1.62 (m, 12H), 1.27-1.23 (m, 6H) 1 H NMR (400 MHz, DMSO- d 6 ): δ 7.90-7.84 (m, 2H), 7.79-7.73 (m, 3H), 7.63-7.61 (m, 2H), 7.31-7.28 (m, 2H), 6.57-6.50 (t, J = 12.6 Hz, 2H), 6.38-6.30 (m, 2H), 4.11-4.09 (d, J = 7.4 Hz, 4H), 1.62 (m, 12H), 1.27-1.23 (m, 6H)
LC/MS, calculated for C31H35N2O6S2 - 595.75, found 595.40 LC / MS, calculated for C 31 H 35 N 2 O 6 S 2 - 595.75, found 595.40
λabs (water) : 744 nm, λfl (water) : 780 nmλ abs (water): 744 nm, λ fl (water): 780 nm
실시예 8: 화합물 1-8의 제조Example 8: Preparation of Compound 1-8
Rf = 0.22 (RP-C18, acetonitrile/water 3:7 v/v)R f = 0.22 (RP-C18, acetonitrile / water 3: 7 v / v)
1H NMR (400 MHz, DMSO-d 6 ) : δ 7.91-7.84 (m, 2H), 7.79-7.73 (m, 3H), 7.62-7.60 (m, 2H), 7.32-7.30 (m, 2H), 6.57-6.50 (m, 2H), 6.40-6.36 (d, J = 13.6 Hz, 2H), 4.05-4.02 (m, 4H), 1.78-1.63 (m, 17H), 0.96-0.89 (m, 6H) 1 H NMR (400 MHz, DMSO- d 6 ): δ 7.91-7.84 (m, 2H), 7.79-7.73 (m, 3H), 7.62-7.60 (m, 2H), 7.32-7.30 (m, 2H), 6.57-6.50 (m, 2H), 6.40-6.36 (d, J = 13.6 Hz, 2H), 4.05-4.02 (m, 4H), 1.78-1.63 (m, 17H), 0.96-0.89 (m, 6H)
LC/MS, calculated for C33H39N2O6S2 - 623.8, found 623.47 LC / MS, calculated for C 33 H 39 N 2 O 6 S 2 - 623.8, found 623.47
λabs (water) : 747 nm, λfl (water) : 783 nmλ abs (water): 747 nm, λ fl (water): 783 nm
실시예 9: 화합물 1-9의 제조Example 9: Preparation of Compound 1-9
(1) 화합물 9-9(1) Compound 9-9
Rf = 0.3 (RP-C18, acetonitrile/water 3:7 v/v)R f = 0.3 (RP-C18, acetonitrile / water 3: 7 v / v)
1H NMR (400 MHz, DMSO-d 6 ) : δ 8.39-8.32 (t, J = 13 Hz, 2H), 7.89-7.81 (m, 2H), 7.64-7.63 (m, 2H), 7.38-7.31 (m, 2H), 6.57 (m, 1H), 6.32-6.29 (d, J = 13.6 Hz, 2H), 4.14-4.12 (m, 4H), 1.67 (m, 12H), 1.26-1.23 (m, 6H) 1 H NMR (400 MHz, DMSO- d 6 ): δ 8.39-8.32 (t, J = 13 Hz, 2H), 7.89-7.81 (m, 2H), 7.64-7.63 (m, 2H), 7.38-7.31 ( m, 2H), 6.57 (m, 1H), 6.32-6.29 (d, J = 13.6 Hz, 2H), 4.14-4.12 (m, 4H), 1.67 (m, 12H), 1.26-1.23 (m, 6H)
LC/MS, calculated for C29H33N2O6S2 - 569.71, found 569.19 LC / MS, calculated for C 29 H 33 N 2 O 6 S 2 - 569.71, found 569.19
λabs (water) : 645 nm, λfl (water) : 668 nmλ abs (water): 645 nm, λ fl (water): 668 nm
실시예 10: 화합물 1-10의 제조Example 10: Preparation of Compound 1-10
Rf = 0.25 (RP-C18, acetonitrile/water 3:7 v/v)R f = 0.25 (RP-C18, acetonitrile / water 3: 7 v / v)
1H NMR (400 MHz, DMSO-d 6 ) : δ 8.39-8.36 (m, 2H), 7.80 (s, 2H), 7.80- 7.61 (m, 2H), 7.34-7.32 (m, 2H), 6.61-6.55 (t, J = 12.3 Hz, 1H), 6.27-6.22 (m, 2H), 4.08-4.04 (m, 4H), 1.74-1.68 (m, 16H), 0.95-0.91 (m, 6H) 1 H NMR (400 MHz, DMSO- d 6 ): δ 8.39-8.36 (m, 2H), 7.80 (s, 2H), 7.80- 7.61 (m, 2H), 7.34-7.32 (m, 2H), 6.61- 6.55 (t, J = 12.3 Hz, 1H), 6.27-6.22 (m, 2H), 4.08-4.04 (m, 4H), 1.74-1.68 (m, 16H), 0.95-0.91 (m, 6H)
LC/MS, calculated for C31H37N2O6S2 - 597.77, found 597.33 LC / MS, calculated for C 31 H 37 N 2 O 6 S 2 - 597.77, found 597.33
λabs (water) : 649 nm, λfl (water) : 669 nmλ abs (water): 649 nm, λ fl (water): 669 nm
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090090957A KR20110033454A (en) | 2009-09-25 | 2009-09-25 | Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090090957A KR20110033454A (en) | 2009-09-25 | 2009-09-25 | Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110033454A true KR20110033454A (en) | 2011-03-31 |
Family
ID=43937858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090090957A KR20110033454A (en) | 2009-09-25 | 2009-09-25 | Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20110033454A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10294204B2 (en) | 2016-04-27 | 2019-05-21 | Bioacts Co., Ltd. | Fluorescence compounds and preparation method thereof |
KR102399778B1 (en) | 2022-02-27 | 2022-05-19 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR102414554B1 (en) | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR102414552B1 (en) | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR102414574B1 (en) | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR20220104454A (en) | 2021-01-18 | 2022-07-26 | (주)바이오액츠 | Fluorescent compound with cyanuric-hydroxide and the preparation method thereof |
-
2009
- 2009-09-25 KR KR1020090090957A patent/KR20110033454A/en not_active Application Discontinuation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10294204B2 (en) | 2016-04-27 | 2019-05-21 | Bioacts Co., Ltd. | Fluorescence compounds and preparation method thereof |
KR20220104454A (en) | 2021-01-18 | 2022-07-26 | (주)바이오액츠 | Fluorescent compound with cyanuric-hydroxide and the preparation method thereof |
KR102399778B1 (en) | 2022-02-27 | 2022-05-19 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR102414554B1 (en) | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR102414552B1 (en) | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
KR102414574B1 (en) | 2022-02-27 | 2022-06-30 | (주)바이오액츠 | Fluorescent compound for detecting biological materials and the preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110033454A (en) | Novel cyanine compound for labeling hydrophobic nanoparticle and preparation method thereof | |
CN110003084B (en) | Organic circular polarization luminescent material with both mechanoluminescence and aggregation-induced luminescence characteristics, and preparation method and application thereof | |
WO2005085811A1 (en) | Fluorescent probes | |
JP6675758B2 (en) | Phosphafluorescein compound or salt thereof, or fluorescent dye using the same | |
CN109734736A (en) | Seven yuan of fluorine boron fluorescent dyes of one kind and its synthetic method | |
JP2005330185A (en) | DITHIA-s-INDACENE DERIVATIVE | |
CN108864733A (en) | A kind of near-infrared carbon rhodamine fluorescent dyes and its synthetic method | |
JP2006265178A (en) | Porphyrin dimer derivative, and separation and purification of carbon nanotube using the same | |
CN112851556A (en) | Novel aggregation-induced emission Golgi fluorescence probe and preparation method and application thereof | |
CN114315696B (en) | Synthesis method of 5-acyl aryl cyclocarbazole compound | |
WO2018181529A1 (en) | Phospha-rhodol compound, salt of same, and fluorescent dye using same | |
JP6009246B2 (en) | Xanthene dye and method for producing the same | |
CN114671851B (en) | Naphthalimide-tetrazine compound and preparation method and application thereof | |
TW202302770A (en) | Xanthene dye, coloring composition containing the dye, colorant for color filter and color filter | |
JP7330456B2 (en) | Curved aromatic compound and method for producing same | |
CN113896675A (en) | Organic luminescent material based on carbazole-triphenylamine derivative and preparation method thereof | |
JP2012007084A (en) | New photosensitizer | |
JP2004189664A (en) | New sulfur-containing multibranched compound | |
CN111620898B (en) | N 2 O-BOBPY fluorescent dye and preparation method and application thereof | |
CN113816974B (en) | Porphyrin covalent connection sym-triazacyclonium compound and preparation and application thereof | |
JP3879201B2 (en) | Sulfonamide compounds and azo compounds | |
JP7297066B2 (en) | Fluorescent compound, its production method and its use | |
CN101735637B (en) | Cyanine dye having azulene structure and preparation method thereof | |
JP4566585B2 (en) | Azo compound, method for producing the same, and material for photosensitive layer | |
JP2800845B2 (en) | Anthracene derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |